Results 191 to 200 of about 171,326 (357)

Intravenous Immunoglobulin Treatment Successfully Improved Subacute Progressive Polyradiculoneuropathy with Polyclonal Gammopathy

, 2009
Kaoru Endo, Naoki Suzuki, Taro Ikenishi, Masashi Aoki, Yasuto Itoyama   +4 more
openalex   +2 more sources

Direct Medical Costs of Liquid Intravenous Immunoglobulins in Children, Adolescents, and Adults in Spain [PDF]

, 2011
Josep Darbà, G Restovic, Lisette Kaskens, T de Agustin   +3 more
openalex   +1 more source

Predictors of Intravenous Immunoglobulin Non-Responsiveness in Children With Kawasaki Disease. [PDF]

Immun Inflamm Dis
Cheng Y, Chen B.
europepmc   +1 more source

Myelitis‐Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late‐Onset Neuromyelitis Optica Spectrum Disorders

Annals of Neurology, EarlyView.
Objective The objective of this study was to compare clinical features and prognosis of late‐onset neuromyelitis optica spectrum disorder (LO‐NMOSD, onset age ≥60 years) with adult‐onset NMOSD (AO‐NMOSD, onset age 18–59 years), and to provide insights for individualized management in elderly patients.
Ya‐Lan Pu, Jin‐Zhou Feng, Hua‐Xing Meng, Hai‐Bing Xiao, Xiao‐Ling Li, Jin Zhen, Wen‐Ying Lu, Xu‐Ming Xi, Ti Wu, Bao‐Shi Yuan, Mo‐Li Fan, Chao Zhang, De‐Cai Tian, Xia Meng, Fu‐Dong Shi, Tian Song   +15 more
wiley   +1 more source

Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction

, 2014
Robert D. M. Hadden, Fabrizio Marreno
openalex   +2 more sources

The Clinical Response of West Nile Virus Neuroinvasive Disease to Intravenous Immunoglobulin Therapy [PDF]

, 2012
Zvi Shimoni, Hanna Bin, Shlomo Bulvik, Mark Niven, Rawi Hazzan, Ella Mendelson, Paul Froom   +6 more
openalex   +1 more source

Comment on the "Use of intravenous immunoglobulin for the treatment of severe COVID-19". [PDF]

South Afr J Crit Care
Aaungsupawong H, Wiwanitkit V.
europepmc   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa [PDF]

, 2013
Petra M. Pego, Inês Câmara, José Pedro Andrade, João Matos Costa   +3 more
openalex   +1 more source

Scleromyxedema Managed With High-Dose Intravenous Immunoglobulin and Bortezomib-Dexamethasone: A Case Report. [PDF]

Case Rep Oncol Med
Wijaya D, Hanson Z, Lau EK, Akhtari M.
europepmc   +1 more source